Bikunin: A Promising Prognostic Biomarker for Acute-on-Chronic Liver Failure in Patients with Viral Hepatitis B

References

• Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. doi:10.1007/s12072-019-09946-3
   PubMed Web of Science ®Google Scholar
• Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386(10003):1576–1587. doi:10.1016/S0140-6736(15)00309-8
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3(1):269–282. doi:10.1007/s12072-008-9106-x
   PubMed Web of Science ®Google Scholar
• Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–2063. doi:10.1016/S0140-6736(14)60220-8
   PubMed Web of Science ®Google Scholar
• Mezzano G, Juanola A, Cardenas A, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022;71(1):148–155. doi:10.1136/gutjnl-2020-322161
   PubMed Web of Science ®Google Scholar
• Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191. doi:10.1136/gutjnl-2017-314641
   PubMed Web of Science ®Google Scholar
• Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038–1047. doi:10.1016/j.jhep.2014.06.012
   PubMed Web of Science ®Google Scholar
• Choudhury A, Jindal A, Maiwall R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11(5):461–471. doi:10.1007/s12072-017-9816-z
   PubMed Web of Science ®Google Scholar
• Li X, Wang W, Chen J. Recent progress in mass spectrometry proteomics for biomedical research. Sci China Life Sci. 2017;60(10):1093–1113. doi:10.1007/s11427-017-9175-2
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Suzuki M, Kanayama N, Terao T. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation. Clin Exp Metastasis. 2004;21(2):159–166. doi:10.1023/b:clin.0000024751.73174.c2
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Suzuki M, Terao T. Upregulation of bikunin in tumor-infiltrating macrophages as a factor of favorable prognosis in ovarian cancer. Gynecol Oncol. 2004;94(3):725–734. doi:10.1016/j.ygyno.2004.06.012
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137–2145. doi:10.1056/NEJMra1914900
   PubMed Web of Science ®Google Scholar
• O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67(6):2367–2374. doi:10.1002/hep.29773
   PubMed Web of Science ®Google Scholar
• Rosenblatt R, Shen N, Tafesh Z, et al. The North American Consortium for the study of end-stage liver disease-acute-on-chronic liver failure score accurately predicts survival: an external validation using a national cohort. Liver Transpl. 2020;26(2):187–195. doi:10.1002/lt.25696
   PubMed Web of Science ®Google Scholar
• Wu D, Zhang S, Xie Z, et al. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J Clin Invest. 2020;130(4):2069–2080. doi:10.1172/JCI130197
   PubMed Web of Science ®Google Scholar
• Sun Z, Liu X, Wu D, et al. Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B. Theranostics. 2019;9(4):1200–1214. doi:10.7150/thno.31991
   PubMed Web of Science ®Google Scholar
• Zhou N, Wang K, Fang S, et al. Discovery of a potential plasma protein biomarker panel for acute-on-chronic liver failure induced by Hepatitis B virus. Front Physiol. 2017;8:1009. doi:10.3389/fphys.2017.01009
   PubMed Web of Science ®Google Scholar
• Claria J, Stauber RE, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64(4):1249–1264. doi:10.1002/hep.28740
   PubMed Web of Science ®Google Scholar
• Haouari W, Dubail J, Lounis-Ouaras S, et al. Serum bikunin isoforms in congenital disorders of glycosylation and linkeropathies. J Inherit Metab Dis. 2020;43(6):1349–1359. doi:10.1002/jimd.12291
   PubMed Web of Science ®Google Scholar
• Lepedda AJ, De Muro P, Capobianco G, Formato M. Role of the small proteoglycan bikunin in human reproduction. Hormones. 2020;19(2):123–133. doi:10.1007/s42000-019-00149-x
   PubMedGoogle Scholar
• Lepedda AJ, Nieddu G, Cannas C, Formato M. Molecular and pathobiological insights of bikunin/UTI in cancer. Mol Biol Rep. 2023;50(2):1701–1711. doi:10.1007/s11033-022-08117-2
   PubMed Web of Science ®Google Scholar
• Lin SD, Takikawa Y, Endo R, Suzuki K. Proinflammatory cytokines up-regulate synthesis and secretion of urinary trypsin inhibitor in human hepatoma HepG2 cells. Hepatol Res. 2004;29(4):243–248. doi:10.1016/j.hepres.2004.04.003
   PubMed Web of Science ®Google Scholar
• Matsuzaki H, Kobayashi H, Yagyu T, et al. Bikunin inhibits lipopolysaccharide-induced tumor necrosis factor alpha induction in macrophages. Clin Diagn Lab Immunol. 2004;11(6):1140–1147. doi:10.1128/CDLI.11.6.1140-1147.2004
   PubMedGoogle Scholar
• Kanayama S, Yamada Y, Onogi A, et al. Molecular structure and function analysis of bikunin on down-regulation of tumor necrosis factor-alpha expression in activated neutrophils. Cytokine. 2008;42(2):191–197. doi:10.1016/j.cyto.2007.12.011
   PubMed Web of Science ®Google Scholar
• Wei X, Zhu X, Jiang L, Long M, Du Y. Recent research progress on the role of ulinastatin in chronic kidney disease. Nephrology. 2021;26(9):708–714. doi:10.1111/nep.13906
   PubMed Web of Science ®Google Scholar
• Lin SD, Endo R, Sato A, Takikawa Y, Shirakawa K, Suzuki K. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis. J Gastroenterol Hepatol. 2002;17(2):140–147. doi:10.1046/j.1440-1746.2002.02676.x
   PubMed Web of Science ®Google Scholar
• Abu-Amara M, Gurusamy KS, Glantzounis G, Fuller B, Davidson BR. Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control. Cochrane Database Syst Rev. 2009;2009(4):CD008154. doi:10.1002/14651858.CD008154
   PubMedGoogle Scholar
• Lu J, Chen YP, Wan R, Guo CY, Wang XP. Protective effects of ulinastatin on acute liver failure induced by lipopolysaccharide/D-galactosamine. Dig Dis Sci. 2012;57(2):399–404. doi:10.1007/s10620-011-1927-0
   PubMed Web of Science ®Google Scholar
• Wang C, Liu T, Tong Y, et al. Ulinastatin protects against Acetaminophen-induced liver injury by alleviating ferroptosis via the SIRT1/NRF2/HO-1 pathway. Am J Transl Res. 2021;13(6):6031–6042.
   PubMed Web of Science ®Google Scholar